MOLLY ANN VIENS APRN NPI 1689288748

NPI Details

Molly Ann Viens, APRN is a family nurse practitioner in Exeter, NH with 6 years of experience. Molly Ann Viens, APRN NPI is 1689288748. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

1 HAMPTON RD STE A306
EXETER, NH
ZIP 03833-848
Phone: (603) 929-1195
Fax: (603) 580-6047

The NPI 1689288748 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Hemoglobin a1c level (HCPCS:83036)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Anticoagulant management of patient taking warfarin (HCPCS:93793)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Blood test, clotting time (HCPCS:85610)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Folic acid level, serum (HCPCS:82746)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Bacterial colony count, urine (HCPCS:87086)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Urine microalbumin (protein) level (HCPCS:82043)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Urinalysis using microscope (HCPCS:81015)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Routine electrocardiogram (ecg) using at least 12 leads with tracing (HCPCS:93005)
• Uric acid level, blood (HCPCS:84550)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Vitamin d-3 level (HCPCS:82306)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Lipase (fat enzyme) level (HCPCS:83690)
• Removal of impacted ear wax by washing (HCPCS:69209)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)

The enumeration date for this NPI number is 9/4/2020 and was last updated on 10/16/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.